Tóth J - Search Results

1

Lack of Correlation Between Survival and Allele Loss on Chromosome 7q31-32 in Primary Breast Cancer.

Sztán M, Besznyák I I, Kovács T, Tóth J, Szémel I I, Oláh E. Sztán M, et al. Among authors: toth j. Pathol Oncol Res. 1996;2(1-2):48-51. doi: 10.1007/BF02893948. Pathol Oncol Res. 1996. PMID: 11173583 Free article.

2

Allelic imbalance and microsatellite instability in BRCA1 associated breast and ovarian tumors.

van der Looij M, Papp J, Sztán M, Pulay T, Elfadil I, Besznyak I, Tóth J, Devilee P, Oláh E. van der Looij M, et al. Among authors: toth j. Int J Oncol. 2001 Apr;18(4):775-80. Int J Oncol. 2001. PMID: 11251173

3

Oncogene patterns in breast and ovarian carcinomas.

Csókay B, Papp J, Besznyák I, Bösze P, Sárosi Z, Tóth J, Zalay Z, Oláh E. Csókay B, et al. Among authors: toth j. Eur J Surg Oncol. 1993 Dec;19(6):593-9. Eur J Surg Oncol. 1993. PMID: 7903645

4

Allele loss from large regions of chromosome 17 is common only in certain histological subtypes of ovarian carcinomas.

Papp J, Csokay B, Bosze P, Zalay Z, Toth J, Ponder B, Olah E. Papp J, et al. Among authors: toth j. Br J Cancer. 1996 Nov;74(10):1592-7. doi: 10.1038/bjc.1996.594. Br J Cancer. 1996. PMID: 8932340 Free PMC article.

5

Correlation of biochemical tumor markers with conventional pathological features in primary breast cancer.

Péley G, Bezzegh A, Besznyák I, Doleschall Z, Csuka O, Péter I, Tóth J, Számel I, Schumann B, Ottó S. Péley G, et al. Among authors: toth j. Int J Biol Markers. 1999 Jan-Mar;14(1):49-51. doi: 10.1177/172460089901400110. Int J Biol Markers. 1999. PMID: 10367251 Free article.

6

Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary.

Van Der Looij M, Szabo C, Besznyak I, Liszka G, Csokay B, Pulay T, Toth J, Devilee P, King MC, Olah E. Van Der Looij M, et al. Among authors: toth j. Int J Cancer. 2000 Jun 1;86(5):737-40. doi: 10.1002/(sici)1097-0215(20000601)86:5<737::aid-ijc21>3.0.co;2-1. Int J Cancer. 2000. PMID: 10797299

7

[Clinical significance of steroid receptors in breast cancer].

Svastics E, Számel I, Ringwald G, Vincze B, Besznyák I, Tóth J. Svastics E, et al. Among authors: toth j. Orv Hetil. 1994 Mar 6;135(10):513-7. Orv Hetil. 1994. PMID: 8146006 Hungarian.

8

[Pseudomyxoma peritonei].

Besznyák I, Pommersheim F, Tóth J. Besznyák I, et al. Among authors: toth j. Orv Hetil. 1996 Dec 15;137(50):2803-7. Orv Hetil. 1996. PMID: 9679616 Review. Hungarian.

9

HER-2/neu genotype of breast cancer may change in bone metastasis.

Lôrincz T, Tóth J, Badalian G, Tímár J, Szendrôi M. Lôrincz T, et al. Among authors: toth j. Pathol Oncol Res. 2006;12(3):149-52. doi: 10.1007/BF02893361. Epub 2006 Sep 23. Pathol Oncol Res. 2006. PMID: 16998594 Free article.

10

Tumor-infiltrating B cell immunoglobulin variable region gene usage in invasive ductal breast carcinoma.

Simsa P, Teillaud JL, Stott DI, Tóth J, Kotlan B. Simsa P, et al. Among authors: toth j. Pathol Oncol Res. 2005;11(2):92-7. doi: 10.1007/BF02893374. Epub 2005 Jul 1. Pathol Oncol Res. 2005. PMID: 15999153 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,200 results

Search Page

Filters